FDA Approves New Flu Drug
The U.S. Food and Drug Administration (FDA) has approved a new drug for the treatment of acute uncomplicated influena (flu). Xofluza (baloxavir marboxil) was approved this week for patients 12 years and older who have been symptomatic for less than 48 hours.
“This is the first new antiviral flu treatment with a novel mechanism of action approved by the FDA in nearly 20 years. With thousands of people getting the flu every year, and many people becoming seriously ill, having safe and effective treatment alternatives is critical. This novel drug provides an important, additional treatment option,” said FDA Commissioner Scott Gottlieb, MD.
Dr. Gottlieb also reminded the public that yearly flu vaccination is the safest and most effective way to protect yourself from the flu.